Take A Stand for Workplace Health: A Sit-stand Workstation Project Evaluation
NCT ID: NCT02172599
Last Updated: 2018-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-05-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
StandUP UBC: Reducing Workplace Sitting
NCT03375749
Take a Stand! - an Intervention to Reduce Occupational Sitting Time
NCT01996176
Cardiometabolic Response to Sit-stand Workstations.
NCT02342301
Stand & Move at Work
NCT02566317
The Effect of Sit-Stand Workstations on Physical Activity in Sedentary Office Workers
NCT01863056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
multi-component intervention
Sit-stand workstation provision
The multi-component intervention will align with the World Health Authority's promotion of a healthy workplace model, which emphasises that best-practice workplace health interventions should involve an integrated approach involving organisation and individual level approaches to behaviour change (WHO, 2010). Thus, participants will receive a sit-stand workstation with additional support to use the sit-stand workstation.
Sit-stand workstation provision
The research compares the effects of a sit-stand workstation only and a multi-component sit-stand workstation intervention including individual and organisation-level approaches, with usual office-based working practice (no sit-stand workstation) over 12 months.
Sit-stand workstation only
Sit-stand workstation provision
Participants in this arm will receive a sit-stand workstation. They will not receive any support to use the sit-stand workstation, except some health and safety advice upon installation.
Sit-stand workstation provision
The research compares the effects of a sit-stand workstation only and a multi-component sit-stand workstation intervention including individual and organisation-level approaches, with usual office-based working practice (no sit-stand workstation) over 12 months.
Usual practice (seated workstation)
This arm is the control group. They will continue to use their usual seated workstation for the duration of the study.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sit-stand workstation provision
The research compares the effects of a sit-stand workstation only and a multi-component sit-stand workstation intervention including individual and organisation-level approaches, with usual office-based working practice (no sit-stand workstation) over 12 months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must engage in primarily desk-based work
* Must have their own desk (i.e. does not hot desk) Must be primarily office based (i.e. not working from home)
* Must have no plans to leave the organisation for an extended period (e.g. holiday \> 4 weeks or secondment) or finitely before the anticipated study end date (January 2016)
Exclusion Criteria
* Have been advised against standing by a health professional; or be unable to stand
* Work for the Macmillan Support Line
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Macmillan Canceer Support
OTHER
Ergotron
UNKNOWN
Public Health England
OTHER_GOV
Brunel University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Hall
PhD Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Hall, BSc
Role: PRINCIPAL_INVESTIGATOR
Brunel University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Public Health England, SKipton House
London, , United Kingdom
Macmillan Cancer Support UK Office
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hall J, Kay T, McConnell A, Mansfield L. "Why would you want to stand?" an account of the lived experience of employees taking part in a workplace sit-stand desk intervention. BMC Public Health. 2019 Dec 17;19(1):1692. doi: 10.1186/s12889-019-8038-9.
Hall J, Mansfield L, Kay T, McConnell AK. The effect of a sit-stand workstation intervention on daily sitting, standing and physical activity: protocol for a 12 month workplace randomised control trial. BMC Public Health. 2015 Feb 15;15:152. doi: 10.1186/s12889-015-1506-y.
Related Links
Access external resources that provide additional context or updates about the study.
This link provides physical activity information for people affected by cancer
This link provides advice on returning to work for people affected by cancer
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R33134
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
TSWH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.